Conference item icon

Conference item

Efficacy and safety of monotherapy with sirukumab, an anti-IL-6 cytokine monoclonal antibody, compared with adalimumab monotherapy in biologic-naive patients with active rheumatoid arthritis: results of a global, randomized, double-blind, parallel-group, phase 3 study

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/art.39977

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS; KIR
Oxford college:
St Peters College
Role:
Author
Expand authors...
Publisher:
Wiley Publisher's website
Volume:
68
Issue:
S10
Pages:
Article: 3222
Publication date:
2016-11-08
DOI:
EISSN:
2326-5205
ISSN:
2326-5191
Pubs id:
pubs:820168
URN:
uri:cf439929-e31a-4d22-97d8-940f2e8f64e2
UUID:
uuid:cf439929-e31a-4d22-97d8-940f2e8f64e2
Local pid:
pubs:820168

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP